MORE►
precision medicine
Eric Matthews, chief business officer, biopharma business development at Caris Life Sciences. [Photo: Caris Life Sciences]
Caris Life Sciences Appoints Chief Business Officer, Biopharma Business Development
by Lance Murray | May 8, 2025
Eric Matthews will provide strategic leadership to biopharma business development, and through his executive leadership, support Caris' expanding portfolio of biopharma partnerships, the company said.
by Lance Murray |
Oct 24, 2023
Irving-based Caris said that via this multiyear agreement, Moderna will leverage Caris’ extensive library of de-identified, multimodal data solutions derived from whole exome sequencing, whole transcriptome sequencing, and protein analyses—along with claims data to improve development strategies for Moderna’s oncology pipeline.
MORE►
by Alex Edwards |
May 12, 2021
Now valued at more than $7.8 billion, Caris specializes in AI-powered genetic sequencing for personalized cancer treatments. The massive capital raise follows a $310 million round in October and boosts the 13-year-old company's total funding to about $1.3 billion.
MORE►
by Alex Edwards |
Oct 27, 2020
The growth capital will allow Caris to advance its position as a leading tumor profiling company that aims to reinvent cancer care.
MORE►
[Photo by ismagilov via iStock]
5 Health Trends to Keep Your Eyes on in 2017
by Hubert Zajicek | Jan 9, 2017
Artificial intelligence, emancipating role of health care consumers, and genetic testing are some of the trends to expect in 2017 Hubert Zajicek says.
MORE►
